跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Maclitax - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Maclitax
Approved
STANDARD
Maclitax
Cisen Pharmaceutical Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
f2c69f14808b53a3
Company
Cisen Pharmaceutical Co., Ltd.
Type
Standard
Approval Details
Approval Id
f2c69f14808b53a3
Drug Approval Philippines Name
Maclitax
Product Name
Maclitax
Registration Number
DRP-15882
Brand Name
Maclitax
Generic Name
Paclitaxel
Dosage Form
Solution for Injection (IV)
Dosage Strength
6 mg/mL (30 mg/5 mL)
Manufacturer
Cisen Pharmaceutical Co., Ltd.
Company Detail Path
/organization/cisen-pharmaceutical-co-ltd-jining-shandong-china
Issuance Date
25 September 2024
Expiry Date
25 September 2029
Pharmacologic Category
Antineoplastic Agent (Taxane)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
f2c69f14808b53a3
Type
Standard
Back to Philippines FDA Approvals